Insulinoma-Accurate Preoperative Localization Is the Key to Management: An Initial Experience
- PMID: 35782810
- PMCID: PMC9240150
- DOI: 10.1007/s13193-022-01534-6
Insulinoma-Accurate Preoperative Localization Is the Key to Management: An Initial Experience
Abstract
Insulinoma is the commonest functioning pancreatic neuroendocrine tumor. The only curative treatment is surgical excision after preoperative localization. A retrospective analysis of nine patients (February 2017-June 2020), 2 males and 7 females, was done for clinical presentation, biochemistry, localization methods, intraoperative findings, postoperative outcome, histopathology reports, and follow-up. Techniques for localization of the tumor were pancreatic protocol triple-phase multi-detector computed tomography (MDCT), endoscopic ultrasound (EUS), Ga 68 DOTANOC PET-CT, and Ga 68 NOTA-exendin-4 PET-CT (GLP1R scan). The mean age was 38 (range 20-68) years and mean duration of symptoms 34 (range 8-120) months, and symptoms of Whipple's triad were present in all cases after a supervised 72-h fast. MDCT localized tumor in 8/9 cases. EUS before MDCT in one patient had also localized tumors. Ga 68 DOTANOC PET-CT detected tumor in 2/4 patients. In one patient, MDCT or DOTANOC PET scan could not localize tumor; GLP1R scan localized tumor accurately. Two patients had associated MEN1 syndrome. All 9 patients underwent surgical resection (four open and five laparoscopic) of tumor-enucleation (3), distal pancreatectomy with splenectomy (3), and pancreatoduodenectomy (PD) (3). The last four procedures and all three enucleations were laparoscopic. Five patients developed postoperative pancreatic fistula (POPF), only one grade B which required percutaneous drain placement. One patient, who had initial open enucleation, developed hypoglycemia after 48 h; PD was performed. All patients were cured and all, except one (who died of upper GI bleed), were alive and disease-free during a mean follow-up of 26 (range 2-41) months. Preoperative localization of insulinoma is important and decides the outcome of surgery in terms of cure. MDCT can localize tumors in most patients; the last resort for localization is the GLP1R scan. Laparoscopic procedures are equally effective compared to open surgery. Considering the benign nature of the disease, enucleation is the procedure of choice.
Keywords: Enucleation; Ga 68 NOTA-exendin-4 PET-CT; Insulinoma; Pancreatic neuroendocrine tumor.
© The Author(s), under exclusive licence to Indian Association of Surgical Oncology 2022.
Conflict of interest statement
Competing InterestsThe authors declare no competing interests.
Figures


Similar articles
-
18F-labeled PEGylated exendin-4 imaging noninvasively differentiates insulinoma from an accessory spleen: the first case report of [18F]FB(ePEG12)12-exendin-4 positron emission tomography/computed tomography for insulinoma.Front Endocrinol (Lausanne). 2023 Aug 31;14:1245573. doi: 10.3389/fendo.2023.1245573. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37720533 Free PMC article.
-
Is laparoscopic resection adequate in patients with neuroendocrine pancreatic tumors?World J Surg. 2008 May;32(5):904-17. doi: 10.1007/s00268-008-9467-2. World J Surg. 2008. PMID: 18264824
-
A 60-year expirience in the treatment of pancreatic insulinoma in the Military Medical Academy, Belgrade, Serbia.Vojnosanit Pregl. 2014 Mar;71(3):293-7. doi: 10.2298/vsp130415048t. Vojnosanit Pregl. 2014. PMID: 24697017
-
Pancreatic insulinomas: Laparoscopic management.World J Gastrointest Endosc. 2015 Nov 10;7(16):1197-207. doi: 10.4253/wjge.v7.i16.1197. World J Gastrointest Endosc. 2015. PMID: 26566426 Free PMC article. Review.
-
Determinants of surgical resection for pancreatic neuroendocrine tumors.J Hepatobiliary Pancreat Sci. 2015 Aug;22(8):610-7. doi: 10.1002/jhbp.224. Epub 2015 Mar 13. J Hepatobiliary Pancreat Sci. 2015. PMID: 25773163 Review.
Cited by
-
18F-DOPA PET/MRI With Carbidopa for the Diagnosis of Hyperinsulinemic Hypoglycemia in an Adolescent Patient.JCEM Case Rep. 2024 Aug 21;2(9):luae153. doi: 10.1210/jcemcr/luae153. eCollection 2024 Sep. JCEM Case Rep. 2024. PMID: 39170749 Free PMC article.
-
Diagnostic Modalities, Management Considerations, and Outcomes of Insulinoma: A Case Series from a Tertiary Care Centre.Indian J Endocrinol Metab. 2024 May-Jun;28(3):279-288. doi: 10.4103/ijem.ijem_359_23. Epub 2024 Jun 26. Indian J Endocrinol Metab. 2024. PMID: 39086573 Free PMC article.
-
Insulinoma Unmasked Post Sleeve Gastrectomy With Incidental Renal Cell Carcinoma: A Rare Case.Cureus. 2024 May 15;16(5):e60395. doi: 10.7759/cureus.60395. eCollection 2024 May. Cureus. 2024. PMID: 38883112 Free PMC article.
-
Clinicopathological Features of Insulinoma: A Single Tertiary Center Experience.Indian J Surg Oncol. 2023 Sep;14(3):564-570. doi: 10.1007/s13193-023-01774-0. Epub 2023 May 23. Indian J Surg Oncol. 2023. PMID: 37900637 Free PMC article.
References
-
- Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol. 2005;19(5):783–798. - PubMed
-
- Öberg K, Eriksson B. Endocrine tumours of the pancreas. Best Pract Res Clin Gastroenterol. 2005;19(5):753–781. - PubMed
-
- Sotoudehmanesh R, Hedayat A, Shirazian N, Shahraeeni S, Ainechi S, Zeinali F, Kolahdoozan S. Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine. 2007;31(3):238–241. - PubMed
LinkOut - more resources
Full Text Sources